HY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Hyster-Yale Inc is not a good buy for a beginner, long-term investor at this time. The company's financial performance is significantly deteriorating, and there are no strong positive catalysts or trading signals to suggest an immediate upside. Analysts have a positive long-term outlook, but the current financial struggles and lack of momentum make it unsuitable for immediate investment.
The MACD is positive but contracting, RSI is neutral at 60.902, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot point of 35.037, with resistance at 37.332 and support at 32.741. Overall, the technical indicators suggest a neutral trend.
Analysts have raised price targets and upgraded the stock, citing potential for long-term growth and recovery in lift-truck shipments in the second half of 2026.
The company's financial performance in Q4 2025 shows significant declines in revenue (-13.52% YoY), net income (-609.71% YoY), and EPS (-610.34% YoY). Gross margin also dropped by 27.04%. There is no recent news or significant trading activity from insiders, hedge funds, or Congress.
In Q4 2025, revenue dropped to $923.2M (-13.52% YoY), net income fell to -$52.5M (-609.71% YoY), EPS declined to -2.96 (-610.34% YoY), and gross margin decreased to 14.19% (-27.04% YoY). These results indicate severe financial struggles.
Analysts have a positive long-term outlook, with Roth Capital raising the price target to $44 and Northland upgrading the stock to Outperform with a $50 price target. They cite strategic initiatives and a potential recovery in lift-truck shipments as reasons for optimism.
